These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

560 related items for PubMed ID: 24160944

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm.
    Su TS, Lu HZ, Cheng T, Zhou Y, Huang Y, Gao YC, Tang MY, Jiang HY, Lian ZP, Hou EC, Liang P.
    BMC Cancer; 2016 Nov 03; 16(1):834. PubMed ID: 27809890
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic outcome and related predictors of stereotactic body radiotherapy for small liver-confined HCC: a systematic review and meta-analysis of observational studies.
    Long Y, Liang Y, Li S, Guo J, Wang Y, Luo Y, Wu Y.
    Radiat Oncol; 2021 Apr 08; 16(1):68. PubMed ID: 33832536
    [Abstract] [Full Text] [Related]

  • 4. The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT).
    Scorsetti M, Comito T, Cozzi L, Clerici E, Tozzi A, Franzese C, Navarria P, Fogliata A, Tomatis S, D'Agostino G, Iftode C, Mancosu P, Ceriani R, Torzilli G.
    J Cancer Res Clin Oncol; 2015 Jul 08; 141(7):1301-9. PubMed ID: 25644863
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Stereotactic body radiotherapy in patients with hepatocellular carcinoma in a multimodal treatment setting.
    Gerum S, Heinz C, Belka C, Walter F, Paprottka PM, De Toni EN, Roeder F.
    Strahlenther Onkol; 2020 Apr 08; 196(4):334-348. PubMed ID: 31732784
    [Abstract] [Full Text] [Related]

  • 8. Clinical outcomes of stereotactic body radiation therapy for small hepatocellular carcinoma.
    Park S, Jung J, Cho B, Kim SY, Yun SC, Lim YS, Lee HC, Park J, Park JH, Kim JH, Yoon SM.
    J Gastroenterol Hepatol; 2020 Nov 08; 35(11):1953-1959. PubMed ID: 32052884
    [Abstract] [Full Text] [Related]

  • 9. Stereotactic Body Radiotherapy for Small Unresectable Hepatocellular Carcinomas.
    Yeung R, Beaton L, Rackley T, Weber B, Hamm J, Lee R, Camborde M, Pearson M, Duzenli C, Loewen SK, Liu M, Ma R, Schellenberg D.
    Clin Oncol (R Coll Radiol); 2019 Jun 08; 31(6):365-373. PubMed ID: 30792051
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Safety and Efficacy of Liver Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma After Segmental Transarterial Radioembolization.
    Hardy-Abeloos C, Lazarev S, Ru M, Kim E, Fischman A, Moshier E, Rosenzweig K, Buckstein M.
    Int J Radiat Oncol Biol Phys; 2019 Dec 01; 105(5):968-976. PubMed ID: 31536781
    [Abstract] [Full Text] [Related]

  • 12. Stereotactic body radiotherapy in hepatocellular carcinoma: patient selection and predictors of outcome and toxicity.
    Loi M, Comito T, Franzese C, Dominici L, Lo Faro L, Clerici E, Franceschini D, Mancosu P, Reggiori G, Gallo P, Badalamenti M, Scorsetti M.
    J Cancer Res Clin Oncol; 2021 Mar 01; 147(3):927-936. PubMed ID: 32945972
    [Abstract] [Full Text] [Related]

  • 13. Stereotactic body radiotherapy based treatment for hepatocellular carcinoma with extensive portal vein tumor thrombosis.
    Shui Y, Yu W, Ren X, Guo Y, Xu J, Ma T, Zhang B, Wu J, Li Q, Hu Q, Shen L, Bai X, Liang T, Wei Q.
    Radiat Oncol; 2018 Sep 25; 13(1):188. PubMed ID: 30253783
    [Abstract] [Full Text] [Related]

  • 14. Dose-Response Relationship in Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: A Pooled Analysis of an Asian Liver Radiation Therapy Group Study.
    Kim N, Cheng J, Huang WY, Kimura T, Zeng ZC, Lee VHF, Kay CS, Seong J.
    Int J Radiat Oncol Biol Phys; 2021 Feb 01; 109(2):464-473. PubMed ID: 33229165
    [Abstract] [Full Text] [Related]

  • 15. A Multi-Institutional Retrospective Study of Repeated Stereotactic Body Radiation Therapy for Intrahepatic Recurrent Hepatocellular Carcinoma.
    Kimura T, Takeda A, Tsurugai Y, Kawano R, Doi Y, Oku Y, Hioki K, Miura H, Nagata Y.
    Int J Radiat Oncol Biol Phys; 2020 Dec 01; 108(5):1265-1275. PubMed ID: 32712256
    [Abstract] [Full Text] [Related]

  • 16. Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization.
    Kang JK, Kim MS, Cho CK, Yang KM, Yoo HJ, Kim JH, Bae SH, Jung DH, Kim KB, Lee DH, Han CJ, Kim J, Park SC, Kim YH.
    Cancer; 2012 Nov 01; 118(21):5424-31. PubMed ID: 22570179
    [Abstract] [Full Text] [Related]

  • 17. Local control by salvage stereotactic body radiotherapy for recurrent/residual hepatocellular carcinoma after other local therapies.
    Kibe Y, Takeda A, Tsurugai Y, Eriguchi T.
    Acta Oncol; 2020 Aug 01; 59(8):888-894. PubMed ID: 32216593
    [Abstract] [Full Text] [Related]

  • 18. Stereotactic body radiotherapy for primary hepatocellular carcinoma.
    Andolino DL, Johnson CS, Maluccio M, Kwo P, Tector AJ, Zook J, Johnstone PA, Cardenes HR.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):e447-53. PubMed ID: 21645977
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.